Trial | NCT00946491  Report issue

Title

To Demonstrate the Relative Bioequivalency of Generic Haloperidol Tablets Versus Haldol in Normal Volunteers
An Open-Label, Single-Dose, Crossover Study to Determine the Bioequivalency of Generic Haloperidol Tablets vs. Haldol in Normal Volunteers.

  • Phase

    Phase 1

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    haloperidol ...

  • Study Participants

    30
To demonstrate the relative bioequivalency of generic Haloperidol tablets versus Haldol in normal volunteers.
Study Started
Apr 30
1987
Primary Completion
May 31
1987
Study Completion
May 31
1987
Last Update
Mar 28
2017

Drug Haloperidol 10 mg Tablets (Cord Laboratories)

Drug Haldol 10 mg Tablets (McNeil Pharmaceuticals)

1 Experimental

Haloperidol 10 mg Tablets (Cord Laboratories)

2 Active Comparator

Haldol 10 mg Tablets (McNeil Pharmaceuticals)

Criteria 

Inclusion Criteria:

No clinically significant abnormal finding on physical exam, medical history, or clinical laboratory results on screening.

Exclusion Criteria:

Positive test results for HIV or hepatitis B or C.
Treatment for drug or alcohol dependence.
No Results Posted